The COVID-19 Pandemic Introduces Diagnostic and Treatment Planning Complexity for Individuals at Clinical High Risk for Psychosis.
The COVID-19 Pandemic Introduces Diagnostic and Treatment Planning Complexity for Individuals at Clinical High Risk for Psychosis.
复制标题
COVID-19大流行为临床精神病高风险的个体引入了诊断和治疗计划的复杂性。
DOI：
10.1093/schbul/sbab083
复制
发表时间：
2021-10-21
影响因子：
6.6
通讯作者：
Strauss GP
中科院分区：
文献类型：
--
作者：
Mittal VA;Walker EF;Strauss GP
COVID-19在全球范围内导致了大量的普遍痛苦和精神疾病患病率的增加。在精神病风险综合征这一临床人群高度异质的领域，情况相当微妙，因为大流行病造成的社会限制减少了一些人的压力，增加了另一些人的压力。此外，一些与流行病有关的社会和文化变化也使这一领域的诊断和治疗前景变得模糊不清。在这篇评论文章中，我们描述了几个典型的情况下，在我们的临床高风险（ESTA）研究项目中看到的演示文稿的代表。这些病例突出了相当大的临床变异性，此外，也说明了诊断医生和治疗提供者目前面临的复杂性。除了讨论这些问题外，本文还介绍了潜在的解决方案，强调了采用数据驱动策略来识别更同质的HIV亚型并采用精准医学的前景。
COVID-19 has led to a great deal of general suffering and an increased prevalence of psychiatric illness worldwide. Within the area of psychosis-risk syndromes, a highly heterogeneous clinical population, the picture is quite nuanced as the social restrictions resulting from the pandemic have reduced stress for some and increased it for others. Further, a number of pandemic-related societal and cultural changes have obfuscated the diagnostic and treatment landscape in this area as well. In this opinion article, we describe several prototypical cases, representative of presentations seen in our clinical high-risk (CHR) research programs. The cases highlight considerable clinical variability and, in addition, speak to the current complexities faced by diagnosticians and treatment providers. In addition to discussing these issues, this piece introduces potential solutions highlighting the promise of incorporating data-driven strategies to identify more homogenous CHR subtypes and employ precision medicine.
登录
查看更多内容
影响因子：
11.3
作者：
Lee HS;Dean D;Baxter T;Griffith T;Park S
通讯作者：
Park S
影响因子：
11.3
作者：
Esposito CM;D'Agostino A;Dell Osso B;Fiorentini A;Prunas C;Callari A;Oldani L;Fontana E;Gargano G;Viscardi B;Giordano B;D'Angelo S;Wiedenmann F;Macellaro M;Giorgetti F;Turtulici N;Gambini O;Brambilla P
通讯作者：
Brambilla P
影响因子：
4.5
作者：
Ryan AT;Addington J;Bearden CE;Cadenhead KS;Cornblatt BA;Mathalon DH;McGlashan TH;Perkins DO;Seidman LJ;Tsuang MT;Woods SW;Cannon TD;Walker EF
通讯作者：
Walker EF
影响因子：
4.5
作者：
Strauss GP;Pelletier-Baldelli A;Visser KF;Walker EF;Mittal VA
通讯作者：
Mittal VA
DOI：
10.1016/j.bpsgos.2021.05.005
发表时间：
2021-12
期刊：
Biological psychiatry global open science
影响因子：
--
作者：
Oh H;Schiffman J;Marsh J;Zhou S;Koyanagi A;DeVylder J
通讯作者：
DeVylder J